Idexx Laboratories (IDXX) Total Non-Current Liabilities (2009 - 2026)

Idexx Laboratories' Total Non-Current Liabilities history runs 18 years deep, the most recent figure standing at $529.5 million for Q1 2026.

• In Q1 2026, Total Non-Current Liabilities fell 15.87% year-over-year to $529.5 million; the TTM figure through Mar 2026 stood at $529.5 million (down 15.87% YoY), while the FY2025 annual figure was $596.6 million, down 5.34% from the prior year.
• Total Non-Current Liabilities for Q1 2026 stood at $529.5 million, down from $596.6 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $983.6 million in Q2 2022, with the low at $529.5 million in Q1 2026.
• The 5-year median for Total Non-Current Liabilities is $818.8 million (2023), against an average of $773.9 million.
• The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities fell 2.17% in 2022, then fell 23.95% in 2025.
• Idexx Laboratories' Total Non-Current Liabilities stood at $902.2 million in 2022, then slipped by 8.69% to $823.8 million in 2023, then slipped by 23.5% to $630.2 million in 2024, then declined by 5.34% to $596.6 million in 2025, then declined by 11.23% to $529.5 million in 2026.
• Business Quant data shows IDXX's Total Non-Current Liabilities at $529.5 million in Q1 2026, $596.6 million in Q4 2025, and $573.7 million in Q3 2025.